Literature DB >> 19915896

Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome.

Luca Di Chiara, Zaccaria Ricci, Cristiana Garisto, Stefano Morelli, Chiara Giorni, Vincenzo Vitale, Roberto M Di Donato, Sergio Picardo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19915896     DOI： 10.1007/s00246-009-9571-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


× No keyword cloud information.
  7 in total

1.  Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.

Authors:  Christian F Stocker; Lara S Shekerdemian; Martin A Nørgaard; Christan P Brizard; Jonathan P Mynard; Steven B Horton; Daniel J Penny
Journal:  Crit Care Med       Date:  2007-01       Impact factor: 7.598

2.  Early experience with Levosimendan in children with ventricular dysfunction.

Authors:  Poongundran Namachivayam; David S Crossland; Warwick W Butt; Lara S Shekerdemian
Journal:  Pediatr Crit Care Med       Date:  2006-09       Impact factor: 3.624

3.  Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation.

Authors:  S Tabbutt; C Ramamoorthy; L M Montenegro; S M Durning; C D Kurth; J M Steven; R I Godinez; T L Spray; G Wernovsky; S C Nicolson
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

4.  Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

Authors:  Alexandre Mebazaa; Markku S Nieminen; Milton Packer; Alain Cohen-Solal; Franz X Kleber; Stuart J Pocock; Roopal Thakkar; Robert J Padley; Pentti Põder; Matti Kivikko
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

5.  A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction.

Authors:  Stefan G De Hert; Suraphong Lorsomradee; Hervé vanden Eede; Stefanie Cromheecke; Philippe J Van der Linden
Journal:  J Cardiothorac Vasc Anesth       Date:  2008-05-14       Impact factor: 2.628

6.  Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.

Authors:  Alain Cohen-Solal; Damien Logeart; Bidan Huang; Danlin Cai; Markku S Nieminen; Alexandre Mebazaa
Journal:  J Am Coll Cardiol       Date:  2009-06-23       Impact factor: 24.094

7.  Hypoxic gas therapy using nitrogen in the preoperative management of neonates with hypoplastic left heart syndrome.

Authors:  N Shime; S Hashimoto; N Hiramatsu; T Oka; K Kageyama; Y Tanaka
Journal:  Pediatr Crit Care Med       Date:  2000-07       Impact factor: 3.624
  7 in total
  2 in total

Review 1.  Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.

Authors:  Johanna Hummel; Gerta Rücker; Brigitte Stiller
Journal:  Cochrane Database Syst Rev       Date:  2017-08-02

2.  Treatment of acute heart failure using levosimendan for a patient with dilated cardiomyopathy, chronic renal failure, and hypertension.

Authors:  Pablo Lobo Martínez; Ignacio Oulego Erroz; Sandra Gautreux Minaya; Luis Miguel Rodríguez Fernández
Journal:  Pediatr Cardiol       Date:  2011-07-10       Impact factor: 1.655
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.